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1. Introduction purchased from Sigma Chemical Co. and other 
chemicals and drugs from Calbiochem. 
In human full-term placentas, cyclic AMP was Indomethacin, prostaglandins and flufenamic 
demonstrated to be involved in the regulation mechanisms acid were respectively given by Merck Sharp Dohme, 
Upjohn and Parke-Davis Laboratories. which control the rate of estrogens biosynthesis 
[ 11. The CAMP intracellular concentration which 
regulates the extent of several physiological phenome- 
na is the result of both enzymatic activities: 
synthesis and degradation of the cyclic nucleotide. 
Previous studies have shown the presence in the 
human placenta of an adenylate cyclase activity [2] 
stimulated by different hormones such as catecho- 
lamines [3,4] and prostaglandins [ 51. An increase 
of CAMP formation was also demonstrated by 
[14C]adenine incorporation after addition of HCG 
[61. 
A cyclic AMP phosphodiesterase activity was 
found in placental homogenates [7], and the present 
work was tindertaken to determine its kinetic pro- 
perties and its sensitivity to different drugs and 
hormones. 
2. Materials and methods 
2.1. Chemicals 
(8-[3H]) cyclic 3’S’-adenosine monophosphate 
(spec. act. 27 Ci/mM) and [14C]adenosine (spec. 
act. 385 mCi/mM) were supplied by CEA Saclay 
France. Anion exchange resin (AGl-X2 200-400 
mesh) was obtained from Bio-Rad. Adenosine 3’5’, 
cyclic monophosphoric acid (CAMP), adenosine 5’ 
monophosphoric acid (S’AMP), imidazole, snake 
venom (Ckoralus atrux), aluminum oxide (neutral 
activity grade I), insulin (bovine pancreas) were 
North-Holland Publishing Company - Amsterdam 
2.2. Enzymatic preparation 
The preparation of the placental homogenates 
was carried out as previously described [2]. 
Freezing at -20°C is not followed by any detec- 
table loss of enzymatic activity during two months. 
2.3. Determination of CAMP phosphodiesterase 
activity 
In the two-stage isotopic procedures employed 
according to Thompson and Appleman [8] : assay I
or to Filburn and Karn [9] : assay II, the S’AMP 
formed from CAMP is converted into adenosine by 
the S’nucleotidase present in the crotalus atrox 
venom. In both methods, reaction mixture contained 
5 X 10-j M Mg-acetate, 8 X lo-* M Tris-HCl 
pH 8.0, 1.5 pa/ml [3H] CAMP, unlabeled CAMP at 
various concentrations and enzymatic preparation. 
At the end of the reaction [‘“Cl adenosine (0.01 
&i/tube) was added as a radioactive tracer. Enzymatic 
activity was calculated from the conversion of 
[ 3H] CAMP into [ 3H] adenosine corrected by the 
recovery of [‘*Cl adenosine (about 68% in assay I, 
92% in assay II) and substraetion of the blank 
values. All the assays were carried out in linearity 
conditions with respect to time and protein concen- 
tration, allowing measurement of the initial rates of 
reaction. Identical results were obtained with the two 
procedures. Proteins were determined by the method 
of Lowry et al. [lo] using bovine serum albumin as 
standard. 
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3. Results 
Kinetic analysis of CAMP phosphodiesterase ctivity 
vs CAMP concentration by double reciprocal plots 
according to Lineweaver and Burk shows two different 
slopes (fig. 1). In the range of CAMP concentration from 
1 X lo-” M to 2 X low5 M and apparent K, I of 
0.97 f 0.12 10e5 M and a Vmax of 629 + 81 pM/min/ 
mg of protein is obtained corresponding to the high 
affinity form. In the range of 2 X lo-’ M to 
5 X 1 0W4 M CAMP a second series of constants i  
determined revealing asecond form of enzymatic 
activity having a lower affinity: K, II = 1.36 + 0.3 X 
1O-4 M, V = 1752 f 360 pM/min/mg of proteins. 
In diffezz tissues, CAMP phosphodiesterase 
activity is stimulated by Mg”. In placental homogenates 
the concentration of this ion determined by atomic 
absorption method is 0.044 + 0.013 mg/g of wet 
tissue. Therefore in our experimental conditions of 
incubation the endogenous Mg” concentration isin 
the 10V4 M range. This fact can explain that without 
any addition of Mg” half of the full activity is 
expressed. Fig.2A shows that the two forms of 
phosphodiesterase ctivity requires additions of 
5 X 10m3 M Mg” in the incubation medium to 
reach maximum activation. 
1 X 10m2 M imidazole stimulates the low affinity 
form about 35% but has no significant effect upon 
the high affinity form (fig.2B). Theophylline is found 
to be a non-competitive inhibitor of the high affinity 
form: K, = 7.1 X 10e4 M, while it appears to be a 
competitive one for the low affinity form: Ki = 
3.6 X 10e3 M (fig.3). Caffeine is somewhat less 
effective and inhibits non-competitively the two 
enzymatic activities. Ki values determined for both 
low range and high range concentrations of substrate 
are respectively 2.7 X 10m3 M and 5.2 X low3 M 
(fig.4). 
Prostaglandins are weak inhibitors of CAMP 
phosphodiesterase ctivity (table 1). PGEl is more . 
potent than PGE2 and the effect of PGb, is not 
significant. The percentage of PGEl inhibition 
begins to increase from 1 X 10e9 M to 1 X 10-s M, 
does not change between 1 X lo-* M and 1 X 10m6 M 
and increases again till 1 X 10-j M. Flufenamic acid, 
indomethacin and progesterone have a strong inhibitory 
action; on the contrary estradiol 170 is less effective. 
The sensitivity of the enzyme, especially to PGE, 
Fig. 1. Kinetic analysis by double reciprocal plot of CAMP phosphodiesterase activity in human placental homogenates. 
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Fig.2. Effect of Mg” (A) and imidazole (B) on human placental CAMP phosphodiesterase activity; on high affinity conditions: 
8 X 1Om6 M CAMP (e-e) and low affinity conditions: 4 X 10e4 M CAMP (X - - - X). Results are expressed in 100% of 
activity measured in the absence of added compound. 
A B 
Fig.3. Inhibition of CAMP phosphodiesterase activity by theophylline in high (A) and low (B) affinity conditions. me 
concentrations of theophylline used are (X-X) none, (A---A) 1 X 10-a M theophylline, (o----o) 5 x LO- 3 M 
theophylline. 
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Fig.4. Inhibition of CAMP phosphodiesterase activity by caffeine in high (A) and low (B) affinity conditions. The concentrations 
of caffeine used are (X-X) none, (i-----A) 4 X 10e3 M caffeine, (e-e) 1 X lo-’ M caffeine. 
flufenamic acid, indomethacin and progesterone, is 
more important at low substrate concentration cor- 
responding to the high affinity activity. 
Lepinephrine (1 X 10S4 M - 1 X 10m3 M), 
norepinephrine (1 X 10m4 M - 1 X 10-j M), FNa 
(1 X 10-s M to 1 X 10e3 M) and insulin (180/.AJ/ml 
to 1800 /AJ/ml) were tested and do not exhibit any 
inhibitory effect of both enzymatic activities. 
Table 1 
Effect of some inhibitors of placental CAMP phosphodiesterase activity at low and 
high substrate concentration 
Additions 
Enzyme activity (% of the control) 
Concentrations 
Low K, conditions High K, conditions 
8 x 1O-6 McAMP 5 X 1O-4 M CAMP 
PGE, lo-’ M 
lo-’ M 
PGE, 1O-3 M 
PGF,, lo-’ M 
Flufenamic acid lo-” M 
Indomethacin 1O-3 M 
Progesterone 1O-4 M 
10-s M 
Estradiol 170 lo-=’ M 
1O-3 M 
78 + 5 
68 + 4 
86 * 5 
95 + 7 
39 t 4 
34 f 4 
66+ 3 
48* 5 
84 f 3 
74 f 5 
89 f 4 
80 + 5 
90 f 6 
96 + 9 
76 f 5 
64 + 7 
72 + 4 
65 f 5 
85 f 2 
82? 3 
Each value represents the mean f SD of duplicate experiments in four different 
placentas. 
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4. Discussion 
Kinetic analysis of the CAMP hydrolysis has shown 
in placental homogenates, as in many other organs, 
the presence of two CAMP phosphodiesterase activities. 
This suggests a regulation depending of the substrate 
concentration. But, it is also possible that there are 
several types of enzymes different by kinetic 
parameters. The placental homogenates contain several 
types of cells which possess perhaps different CAMP 
phosphodiesterase. An other explanation would be a 
different regulation of the part of activity which has 
been demonstrated to be associated with particulate 
fractions [ 71. 
Both low and high affinity phosphodiesterase 
activities require Mg” but imidazole stimulates only 
the low affmity form. 
A complex inhibition by theophylline similar to 
that we observed was found by Schonhofer in isolated 
fat cells [ 111. Our results show that caffeine acts 
non-competitively at low and high substrate concen- 
tration. The high affinity activity is more sensitive 
to inhibitory effect of methylxanthines, prostaglandins, 
flufenamic acid, indomethacin and progesterone and 
is probably more responsible of physiological and 
pharmacological events during pregnancy. 
The weak inhibitory effect of prostaglandins of 
the E series [ 121 is of great interest with regard to 
the results of Satoh and Ryan [S] who found a 
stimulatory action of those compound on placental 
adenylate cyclase activity. The intra-tissular increase 
of CAMP level obtained during placental perfusion 
experiments, after addition of PCEr 1131 is there- 
fore the consequence of at least two different effects 
on the enzymes responsible of formation and 
breakdown of the cyclic nucleotide. The inhibition 
of placental CAMP phosphodiesterase activity by 
indomethacin and flufenamic acid which play a 
role in the synthesis or/and the action of prosta- 
glandins is similar to that observed in bovine heart 
preparation [ 141 and could explain several paradoxal 
effects obtained with those compounds [ 151. 
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